Irisys SafeCount Live Occupancy Monitoring Solution Automates Occupancy Compliance and Enables Social Distancing for Buildings and Rooms With One or Multiple Entrances
28.7.2020 13:00:00 EEST | Business Wire | Press release
The COVID-19 pandemic has created an urgent need to accurately and efficiently manage occupancy regulations and enable social distancing in corporate workspaces, higher education buildings, retail stores, and manufacturing facilities. The Irisys SafeCount™ Live Occupancy Monitoring Solution helps businesses comply with social distancing and occupancy guidelines by anonymously counting people as they enter and exit buildings and rooms.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200728005318/en/
Suitable for buildings of all sizes, even those with multiple entrances and exits, SafeCount delivers live occupancy data with visual warnings and alerts when limits are approached or exceeded. (Photo: Business Wire)
Suitable for buildings of all sizes, even those with multiple entrances and exits, SafeCount delivers live occupancy data with visual warnings and alerts when limits are approached or exceeded.
Built on the advanced Irisys Vector 4D people counting sensor, SafeCount features:
- Easy, fast installation — Simple setup and configuration in less than 30 minutes.
- Highly accurate — Better than 99 percent sensor accuracy that is unaffected by environmental conditions or large crowds.
- Privacy protection — no personally identifiable information is captured by the system.
- Staff detection — advanced functionality can exclude staff from occupancy count.
- Standalone system, yet scalable — SafeCount works separately from existing IT networks and you can add the optional SafeCount Plus cloud platform for remote management and reporting.
“The Irisys SafeCount dashboard puts real-time occupancy data in the hands of attendants and managers while the historical reports provide an audit trail for social distancing compliance,” said Mike Slevin, director of sales at Irisys “Perhaps more importantly, SafeCount gives customers, employees, and visitors peace of mind that your company is protecting their health and safety.”
The SafeCount Plus cloud platform supports an unlimited number of buildings in different locations and time zones. Its advanced reporting enables managers to easily review, compare and analyze occupancy data to identify locations that are not complying with occupancy restrictions, allowing them to take action.
For more information on Irisys SafeCount Live Occupancy Monitoring, visit: https://www.irisys.net/products/safecount-occupancy-monitoring-solution.
About Irisys
Infrared Integrated Systems Ltd, generally called Irisys, is the largest global provider of people counting and real-time queue management solutions. The company’s technology is use by major organizations globally in sectors varying from retail, banks, transport to leisure facilities and public buildings. The systems give operators an unprecedented insight into their business, giving them the information they need to improve customer service, operational efficiency, and profitability. Companies often find opportunities for rapid improvements in their business, and a quick return on investment.
In 2012, Irisys became part of the Fluke Corporation, a worldwide leader in calibration and handheld test instruments. Fluke is world famous for the durability of its test tools and offers a range of tough electrical test tools, infrared thermometers, thermal imagers, and other devices designed for extreme field use.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200728005318/en/
Contact information
Rebecca Rader
(206) 372-1159
rebecca@paynespencer.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Avanzanite Expands French Operations and Appoints Constance Sabbagh as General Manager24.3.2026 08:00:00 EET | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh as General Manager, France. Following a €32 million Series A investment by MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries – designed to bring rare disease medicines to patients in every European market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323639110/en/ Constance Sabbagh, General Manager, France “France is essential to Avanzanite’s European vision,” said Adam Plich, Co-founder and CEO of Avanzanite. “With its leadership in rare disease policy through its National Rare Disease Plans, care networks and scientific innovation, France is one of the most significant healthcare
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs24.3.2026 08:00:00 EET | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, will present the latest updates on its innovations across its broad portfolio at the 2026 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 27-31 in Denver, Colorado. Twenty-two abstracts will be presented, including late-breaking data and three oral presentations spanning Therapeutic Dermatology, Injectable Aesthetics, and Dermatological Skincare. “Galderma is on a path towards becoming the undisputed dermatology powerhouse and, as such, aims to set the bar for scientific excellence in the field. The range of data we are presenting at AAD shows the strength of our commitment to this across every part of our portfolio. Patients deserve sophisticated, effective solutions that meet their diverse and evolving needs, and our science is built to deliver exactly that.” BALDO SCASSELLATI SFORZOLINI, M.D., PH.D. GLOBAL HEAD OF R&D AND CORPORATE DEVELOPMENT GALDERMA Therapeutic Dermatology: Latest updat
Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved24.3.2026 08:00:00 EET | Press release
Curatis Holding AG (SIX:CURN, “Curatis”) reports business revenues of CHF 10.8m (+57%) for 2025. Curatis AG increased sales in its distribution business organically by 13%, from CHF 9.5m to CHF 10.8m. The net result improved from a loss of CHF 4.3m in 2024 to a loss of CHF 1.4m in 2025. Further key statements In September 2025, our development plan for corticorelin was validated at a meeting with the FDA, enabling Curatis to proceed toward a regulatory submission supporting a pivotal study in patients suffering from peritumoral brain edema (PTBE). In November 2025, Curatis raised CHF 1.2m to progress corticorelin. The cash position as of year end 2025 was comfortable, standing at CHF 1.9m. Recently, Curatis announced a license agreement for corticorelin for Japan with significant milestone payments. Business development and finances In 2025, product sales amounted to CHF 10.3m, while service revenue amounted to CHF 0.5m. On a full year basis, Curatis AG increased revenues in its distri
HJS Foundation Releases JEP Protocol & HJS Framework: The "Black Box" for AI, Enabling Verifiable Human Oversight24.3.2026 05:36:00 EET | Press release
HJS Foundation (Human Judgment Systems Foundation) today released two complementary solutions: the Judgment Event Protocol (JEP) and the Human Judgment Structure (HJS) framework. As a minimalist open standard, JEP generates tamper-proof records of AI decision accountability, just like an aircraft black box; HJS embeds human judgment logic into AI operation processes — together, they transform "human oversight" from a regulatory requirement into a verifiable technical fact, providing an optional technical solution for AI accountability. How to prove that AI decisions (such as loan approvals, medical diagnoses, border screenings, etc.) have undergone human review? JEP generates immutable audit trails of human intervention through four cryptographic primitives — Judge, Verify, Delegate, Terminate; HJS builds a controllable and accountable system to prevent risks such as AI drift and ensure that human judgment guides AI operations. Current systems rely on alterable post-hoc documentation,
Access Advance Welcomes New VDP Pool Licensors and Releases Independent Economic Analysis Confirming FRAND Compliance24.3.2026 02:00:00 EET | Press release
Access Advance LLC today announced that Sharp Corporation, CB Cline, SK Planet, and Telechips, Inc have joined the Access Advance Video Distribution Patent Pool (VDP Pool) as Licensors, further expanding the pool's portfolio of patents for modern video codec technologies (HEVC, VVC, VP9, and AV1). The announcement coincides with the release of an independent economic analysis by Criterion Economics confirming that the VDP Pool's royalty structure is fair, reasonable, and nondiscriminatory (FRAND). Sharp, a global leader in consumer electronics and display technologies, brings decades of research and development in video processing and compression to the VDP Pool. The additions of CB Cline, SK Planet, and Telechips, Inc further expand the pool’s patent coverage. These additions reinforce the VDP Pool’s position as the leading licensing program for modern video codec technologies powering the streaming experiences of consumers worldwide. "Sharp, CB Cline, SK Planet, and Telechips each br
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
